We analyze noise-free headlines and recent hype associated with New Capital Dynamic European Eq USD Ord which may create opportunities for some arbitrage if properly timed. With New Capital hype-based prediction module you can estimate the value of New Capital Dynamic European Eq USD Ord from the prospective of New Capital response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on New Capital over a specific investment horizon. Please also check Risk vs Return Analysis.
|Horizon||30 Days Login to change|
New Capital After-Hype Price Density Analysis
Next price density
New Capital Estimiated After-Hype Price Volatility
December 18, 2018
New Capital is Unknown risk asset. Analysis and calculation of next after-hype price of New Capital Dynamic is based on 2 months time horizon.
New Capital Next Price Analysis
|Daily Expected return||Period Volatility||Hype elasticity||Related hype elasticity||Average news density||Related news density||Next Expected Hype|
|1.29%||1.86%||0.00%||0.38%||0 Events / Month||0 Events / Month||Uncertain|
|Latest traded price||Expected after-news price||Potential return on next major news||Average after-hype volatility|
New Capital Hype TimelineNew Capital Dynamic European Eq USD Ord is currently traded for 136.14on Irland Stock Exchange of Ireland. This company stock is not elastic to its hype. The average elasticity to hype of competition is -0.38. New Capital Dynamic European Eq USD Ord is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at -1.29%. The volatility of relative hype elasticity to New Capital is about 636.99%%. The volatility of related hype on New Capital is about 636.99% with expected price after next announcement by competition of 135.76. The company had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be uncertain. Please also check Risk vs Return Analysis.
New Capital Related Hype Analysis
|Acquisition by Amy Schulman of 212 shares of Ironwood Pharmaceuticals subject to Rule 16b 3December 18, 2018 for Amy Schulman|
|Exercise or conversion by David Cooper of 898 shares of WEX subject to Rule 16b 3December 18, 2018 for David Cooper|
|View All Premium Stories|
Investors are also interested in
Purchased over 90 shares
Active a day ago